• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,456.40 1,387.95
( 1.87%)
Global Indices
Nasdaq
46,146.75 -82.73
(-0.18%)
Dow Jones
6,578.03 -23.97
(-0.36%)
Hang Seng
52,101.04 585.55
(1.14%)
Nikkei 225
9,942.10 47.95
(0.48%)
Forex
USD-INR
93.53 0.04
(0.04%)
EUR-INR
108.22 0.07
(0.07%)
GBP-INR
125.01 0.33
(0.27%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

The Ravalgaon Sugar Farm Ltd
Industry :  Food - Processing - Indian
BSE Code
ISIN Demat
Book Value()
507300
INE615A01025
443.85
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RAVALSUGAR
0
29.55
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

sylph technologies ltd
Astrazeneca Pharma and Sun Pharma form second brand partnership
Nov 17,2025
Astrazeneca Pharma India and Sun Pharmaceutical Industries announced a second brand partnership for Sodium Zirconium Cyclosilicate (SZC) in India. This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India. Under the agreement, both companies will promote, market & distribute SZC in India under different brand names; AstraZeneca will market SZC as Lokelma® whereas Sun Pharma will promote and distribute the therapy as Gimliand®. AstraZeneca will retain the intellectual property rights to SZC and hold the Marketing Authorisation along with the import license of the molecule.